$8.56 3.4%
TMCI Stock Price vs. AI Score
Data gathered: November 27

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Treace Medical Concepts (TMCI)

Analysis generated July 22, 2024. Powered by Chat GPT.

Treace Medical Concepts is a medical device company that specializes in foot-related surgical products. Their primary focus is on providing innovative solutions designed to improve outcomes for patients undergoing reconstructive surgery. The company is known for its Lapiplasty® 3D Bunion Correction System which has gained significant traction among podiatric and orthopedic surgeons. Their business model revolves around leveraging advanced surgical techniques to cater to an underserved market in foot correction procedures.

Read full AI stock Analysis

Stock Alerts - Treace Medical Concepts (TMCI)

company logo Treace Medical Concepts | November 25
Price is up by 5.1% in the last 24h.
company logo Treace Medical Concepts | November 19
Price is up by 5.2% in the last 24h.
company logo Treace Medical Concepts | November 6
Price is up by 31.9% in the last 24h.
company logo Treace Medical Concepts | November 5
AI Score is up by 20.7% in the last couple of days.

About Treace Medical Concepts

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals in the United States.


Treace Medical Concepts
Price $8.56
Target Price Sign up
Volume 182,670
Market Cap $516M
Year Range $4.17 - $13.05
Dividend Yield 0%
Analyst Rating 0% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2445M9M36M-15M-15M-0.250
Q2 '2444M8.8M36M-21M-19M-0.290
Q1 '2451M10M41M-19M-17M-0.300
Q4 '2362M11M51M-6.3M-6.5M-0.100
Q3 '2341M8M33M-18M-18M-0.280

Insider Transactions View All

Treace John T. filed to buy 6,523,095 shares at $5.3.
September 17 '24
TREACE JAMES T filed to buy 1,223,441 shares at $6.
August 19 '24
Treace John T. filed to buy 6,473,095 shares at $6.
August 15 '24
Treace John T. filed to buy 6,388,095 shares at $5.9.
June 11 '24
TREACE JAMES T filed to buy 1,139,441 shares at $6.1.
June 3 '24

What is the Market Cap of Treace Medical Concepts?

The Market Cap of Treace Medical Concepts is $516M.

What is the current stock price of Treace Medical Concepts?

Currently, the price of one share of Treace Medical Concepts stock is $8.56.

How can I analyze the TMCI stock price chart for investment decisions?

The TMCI stock price chart above provides a comprehensive visual representation of Treace Medical Concepts' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Treace Medical Concepts shares. Our platform offers an up-to-date TMCI stock price chart, along with technical data analysis and alternative data insights.

Does TMCI offer dividends to its shareholders?

As of our latest update, Treace Medical Concepts (TMCI) does not offer dividends to its shareholders. Investors interested in Treace Medical Concepts should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Treace Medical Concepts?

Some of the similar stocks of Treace Medical Concepts are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.